Back to search
FDAFDA · Food and drugs·Recall number D-0307-2022

Succinylcholine Chloride Injection, 200 mg per 10 mL (20 mg per mL), 1,000 mL, Rx only, SterRx, 141 Idaho Avenue, Plattsburgh, NY 12903, NDC 70324-826-01.

Published January 5, 2022 · Recall initiated: November 12, 2021

Summary

FDA records drug Class II recall D-0307-2022, published January 5, 2022 and initiated November 12, 2021. Recalling firm: SterRx, LLC; Status: Terminated; Reported quantity: 3540 bags; Lot: S21367/CBA 18-Nov-21 S21403/CCL 9-Dec-21. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
SterRx, LLC
Distributor
U.S.A. Nationwide
Lot
S21367/CBA 18-Nov-21 S21403/CCL 9-Dec-21
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Succinylcholine Chloride Injection, 200 mg per 10 mL (20 mg per mL), 1,000 mL, Rx only, SterRx, 141 Idaho Avenue, Plattsburgh, NY 12903, NDC 70324-826-01. recalled?

Yes. FDA published recall D-0307-2022 on January 5, 2022. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Press Release